These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37578954)

  • 1. Development of a relationship counselling website to identify and mitigate risk of intimate partner violence in the context of women's PrEP use.
    Hartmann M; Roberts ST; Triplett N; Tenza S; Maboa O; Mampuru L; Mayisela N; Mbewe D; Tolley EE; Reddy K; Palanee-Phillips T; Montgomery ET
    PLOS Digit Health; 2023 Aug; 2(8):e0000329. PubMed ID: 37578954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in relationships, HIV risk, and feelings towards PrEP: findings from a qualitative explanatory study among participants in the CHARISMA intervention trial.
    Hartmann M; Triplett N; Roberts ST; Lanham M; Reddy K; Tenza S; Mayisela N; Mbewe D; Maboa O; Mampuru L; Tolley EE; Palanee-Phillips T; Montgomery ET
    BMC Womens Health; 2023 Aug; 23(1):440. PubMed ID: 37608373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study.
    Wilson EK; Wagner LD; Palanee-Phillips T; Roberts ST; Tolley EE; Mathebula F; Pascoe L; Lanham M; Wilcher R; Montgomery ET;
    BMC Womens Health; 2021 Mar; 21(1):126. PubMed ID: 33766006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.
    Hartmann M; Lanham M; Palanee-Phillips T; Mathebula F; Tolley EE; Peacock D; Pascoe L; Zissette S; Roberts ST; Wagner D; Wilson E; Ayub A; Wilcher R; Montgomery ET;
    AIDS Educ Prev; 2019 Oct; 31(5):433-451. PubMed ID: 31550193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa.
    Montgomery ET; Roberts ST; Reddy K; Tolley EE; Hartmann M; Mathebula F; Wagner LD; Lanham M; Wilcher R; Browne EN; Baeten JM; Palanee-Phillips T
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):425-433. PubMed ID: 35416797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intimate Partner Violence and Pre-exposure Prophylaxis (PrEP): A Rapid Review of Current Evidence for Women's HIV Prevention.
    O'Malley TL; Hawk ME; Egan JE; Krier SE; Burke JG
    AIDS Behav; 2020 May; 24(5):1342-1357. PubMed ID: 31776819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining Associations Between Mental Health, IPV Exposure, HIV Risk Behaviors, and PrEP Use in South African Women: An Analysis of Data from the Charisma Study.
    Triplett NS; Roberts ST; Hartmann M; Wagner D; Reddy KR; Mathebula F; Tolley EE; Baeten JM; Palanee-Phillips T; Montgomery ET
    AIDS Behav; 2023 Jun; 27(6):2030-2040. PubMed ID: 36459264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "You Never Know What Could Happen": Women's Perspectives of Pre-Exposure Prophylaxis in the Context of Recent Intimate Partner Violence.
    Willie TC; Keene DE; Kershaw TS; Stockman JK
    Womens Health Issues; 2020; 30(1):41-48. PubMed ID: 31537431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and initial validation of a simple tool to screen for partner support or opposition to HIV prevention product use.
    Tolley EE; Zissette S; Martinez A; Palanee-Phillips T; Mathebula F; Tenza S; Hartmann M; Montgomery ET
    PLoS One; 2020; 15(12):e0242881. PubMed ID: 33351805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intimate Partner Violence, HIV Pre-Exposure Prophylaxis (PrEP) Acceptability, and Attitudes About Use: Perspectives of Women Seeking Care at a Family Planning Clinic.
    O'Malley TL; Egan JE; Hawk ME; Krier SE; Burke JG
    AIDS Behav; 2021 Feb; 25(2):427-437. PubMed ID: 32813087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the feasibility and acceptability of integrating screening for gender-based violence into HIV counselling and testing for adolescent girls and young women in Tanzania and South Africa.
    Colombini M; Scorgie F; Stangl A; Harvey S; Ramskin L; Khoza N; Mashauri E; Baron D; Lees S; Kapiga S; Watts C; Delany-Moretlwe S;
    BMC Public Health; 2021 Mar; 21(1):433. PubMed ID: 33658000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Game Plan, a Web-Based Intervention to Improve Adherence and Persistence to HIV Pre-exposure Prophylaxis and Reduce Heavy Drinking in Gay, Bisexual, and Other Men Who Have Sex With Men: Usability and User Experience Testing.
    Wray TB; Chan PA; Kahler CW
    JMIR Form Res; 2021 Nov; 5(11):e31843. PubMed ID: 34783662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and acceptability of pre-exposure prophylaxis use among women in violent relationships.
    Braksmajer A; Leblanc NM; El-Bassel N; Urban MA; McMahon JM
    AIDS Care; 2019 Apr; 31(4):475-480. PubMed ID: 30045629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for use of a healthy relationships assessment tool in the CHARISMA pilot study.
    Tolley EE; Martinez A; Zissette S; Palanee-Phillips T; Mathebula F; Tenza S; Hartmann M; Montgomery ET
    PLoS One; 2021; 16(12):e0261526. PubMed ID: 34972141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'If the Partner Finds Out, then there's Trouble': Provider Perspectives on Safety Planning and Partner Interference When Offering HIV Pre-exposure Prophylaxis (PrEP) to Women Experiencing Intimate Partner Violence (IPV).
    Jeffers NK; Zemlak JL; Celius L; Willie TC; Kershaw T; Alexander KA
    AIDS Behav; 2022 Jul; 26(7):2266-2278. PubMed ID: 35032282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An online healthy relationship tool and safety decision aid for women experiencing intimate partner violence (I-DECIDE): a randomised controlled trial.
    Hegarty K; Tarzia L; Valpied J; Murray E; Humphreys C; Taft A; Novy K; Gold L; Glass N
    Lancet Public Health; 2019 Jun; 4(6):e301-e310. PubMed ID: 31155223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to accessing pre-exposure prophylaxis among women experiencing intimate partner violence in the United States: a systematic literature review.
    Kim H; Martin E
    AIDS Care; 2023 Apr; 35(4):509-523. PubMed ID: 36102031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tailored online safety and health intervention for women experiencing intimate partner violence: the iCAN Plan 4 Safety randomized controlled trial protocol.
    Ford-Gilboe M; Varcoe C; Scott-Storey K; Wuest J; Case J; Currie LM; Glass N; Hodgins M; MacMillan H; Perrin N; Wathen CN
    BMC Public Health; 2017 Mar; 17(1):273. PubMed ID: 28327116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intersection of Intimate Partner Violence and Pre-Exposure Prophylaxis: Exploring HIV Worry and PrEP Acceptability Among Women.
    O'Malley TL; Egan JE; Hawk ME; Krier SE; Burke JG
    Violence Against Women; 2021 Nov; 27(14):2600-2616. PubMed ID: 33211622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.